(Q34030600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Effects of growth hormone treatment in children with Prader-Willi syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Lee PD

series ordinal

1

1 reference

30 July 2017

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

Growth Hormone & I G F Research

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

10 Suppl B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

S75-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of methylation analysis for diagnostic testing in 258 referrals suspected of Prader-Willi or Angelman syndromes

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Reference values for height and weight in Prader-Willi syndrome based on 315 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Peculiar body composition in patients with Prader-Labhart-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Relationships Among the Secretion of ACTH, GH, and Cortisol During the Insulin-Induced Hypoglycemia Test in the Normal and Obese Child

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Linear growth response to exogenous growth hormone in Prader-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone secretion in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

The growth hormone response to hexarelin in patients with Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Impairment of growth hormone responsiveness to growth hormone releasing hormone and pyridostigmine in patients affected by Prader-Labhardt-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Photoanthropometric study of craniofacial traits in individuals with Prader-Willi syndrome on short-term growth hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Effect of growth hormone on height, weight, and body composition in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

One-year results of growth hormone treatment of short stature in Prader-Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Prader-Willi syndrome with elevated follicle stimulating hormone levels and diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Neuropsychological factors associated with borderline pathology in children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Prader-Willi Syndrome after age 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

Adults with Prader-Willi syndrome: a survey of 232 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2800%2980014-3

7 January 2021

10.1016/S1096-6374(00)80014-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10984258%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference